Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/27/2026 | CALL | $24.00 | 1,069 | +230 | +27.41% |
| 03/27/2026 | CALL | $23.50 | 372 | +128 | +52.46% |
| 03/27/2026 | CALL | $22.00 | 424 | +114 | +36.77% |
| 03/27/2026 | CALL | $22.50 | 194 | +84 | +76.36% |
| 04/10/2026 | PUT | $20.50 | 76 | +75 | +7,500.00% |
| 01/21/2028 | CALL | $20.00 | 788 | +75 | +10.52% |
| 04/17/2026 | CALL | $22.50 | 321 | -76 | -19.14% |
| 03/27/2026 | PUT | $23.50 | 32 | -106 | -76.81% |
| 01/15/2027 | CALL | $20.00 | 1,819 | -118 | -6.09% |
| 03/27/2026 | PUT | $23.00 | 118 | -119 | -50.21% |
| 01/21/2028 | CALL | $30.00 | 722 | -204 | -22.03% |
| 03/27/2026 | CALL | $26.00 | 129 | -408 | -75.98% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.72% | 2.53M | 273.3M |
| Vanguard Small-Cap Index Fund | 2.31% | 2.15M | 232.01M |
| Vanguard Specialized-Health Care Fund | 2.04% | 1.9M | 205.62M |
| Vanguard Small-Cap Growth Index Fund | 1.33% | 1.24M | 134M |
| Vanguard Extended Market Index Fund | 1.28% | 1.19M | 128.34M |
| Janus Henderson Enterprise Fund | 1.15% | 1.07M | 115.88M |
| Janus Henderson Global Life Sciences Fund | 1.02% | 950.82k | 102.68M |
| Janus Henderson Triton Fund | 0.89% | 832.6k | 89.91M |
| BNY Mellon Small/Mid Cap Growth Fund | 0.81% | 756.27k | 81.67M |
| iShares NASDAQ Biotechnology ETF | 0.71% | 658.49k | 71.11M |
Nasdaq 100 Enters Correction As 30-Year Yields Near 5%: What's Moving Markets Friday?
03/27 01:09 pm
Benzinga
Read moreStock Market Today: Dow Futures Gain, S&P 500 Slips As Investors Brace For Mega-Cap Earnings— Brand Engagement, Nucor In Focus (UPDATED)
01/26 09:41 am
Benzinga
Read more2 Beaten-Down Stocks That Could Sink Even More in 2026
01/21 11:30 pm
The Motley Fool
Read moreSilver Breaks Above $70, Novo Nordisk Soars 9% On Obesity Pill Approval: What's Moving Markets Tuesday? (CORRECTED)
12/24 10:14 am
Benzinga
Read moreSarepta Stock Dumps: Pharma Bro Martin Shkreli Still Likes It
11/04 01:11 pm
Benzinga
Read moreAAV Gene Therapy Market Size to Skyrocket at 40.1% CAGR by 2034
10/07 11:00 am
GlobeNewswire Inc.
Read more2 Beaten-Down Stocks to Avoid Right Now
09/05 09:30 am
The Motley Fool
Read moreSRPT Stock Alert: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Sarepta Therapeutics, Inc. Class Action
08/29 03:13 pm
GlobeNewswire Inc.
Read moreGenetic Material Market Size, Trends and Top Companies (2025 – 2034 Forecast Period)
08/28 11:00 am
GlobeNewswire Inc.
Read moreSRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/25 03:10 am
Benzinga
Read moreSRPT FINAL DEADLINE ALERT: Hagens Berman Urges Sarepta Investors to Act Before August 25 Deadline in Securities Class Action
08/23 04:48 pm
GlobeNewswire Inc.
Read moreSRPT FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – SRPT
08/21 09:19 pm
GlobeNewswire Inc.
Read moreSRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
08/20 04:00 pm
GlobeNewswire Inc.
Read moreRobbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT
08/18 05:56 pm
GlobeNewswire Inc.
Read moreSRPT LOSS ALERT: Sarepta Therapeutics, Inc. Investors with Losses are Reminded of the August 25 Class Action Deadline – Contact BFA Law (NASDAQ:SRPT)
08/17 07:23 am
GlobeNewswire Inc.
Read moreSRPT IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – SRPT
08/16 05:17 pm
GlobeNewswire Inc.
Read moreSAREPTA LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. and Encourages Investors to Contact the Firm Before the August 25th Deadline
08/16 11:50 am
GlobeNewswire Inc.
Read moreSRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
08/15 04:00 pm
GlobeNewswire Inc.
Read moreSRPT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
08/10 08:24 am
GlobeNewswire Inc.
Read moreSRPT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
08/07 06:59 pm
GlobeNewswire Inc.
Read moreSAREPTA LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. and Encourages Investors to Contact the Firm
08/05 07:26 pm
GlobeNewswire Inc.
Read moreSarepta Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion
08/05 06:00 pm
GlobeNewswire Inc.
Read moreROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
08/03 11:40 pm
GlobeNewswire Inc.
Read moreFLYW LEGAL ALERT: Lose Money on Your Flywire Corporation Investment? Contact BFA Law by September 23 Class Action Deadline (NASDAQ:FLYW)
08/03 07:07 am
GlobeNewswire Inc.
Read moreSRPT LEGAL ALERT: Lose Money on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NASDAQ:SRPT)
08/03 07:07 am
GlobeNewswire Inc.
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sarepta and Petco and Encourages Investors to Contact the Firm
08/02 01:54 am
GlobeNewswire Inc.
Read moreSRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
08/01 04:00 pm
GlobeNewswire Inc.
Read moreSRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
07/31 04:19 am
Benzinga
Read moreAMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?
07/29 01:27 pm
Benzinga
Read moreHIMS and SRPT ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
07/28 07:31 pm
GlobeNewswire Inc.
Read moreSarepta Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion.
07/28 04:54 pm
GlobeNewswire Inc.
Read moreDuchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsight
07/28 01:00 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT
07/28 10:52 am
GlobeNewswire Inc.
Read moreSRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
07/28 10:36 am
Benzinga
Read moreSRPT STOCK UPDATE: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is being Sued for Securities Fraud – Contact BFA Law by August 25 Class Action Deadline
07/26 07:07 am
GlobeNewswire Inc.
Read moreSRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
07/25 04:00 pm
GlobeNewswire Inc.
Read moreRoche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU
07/25 07:00 am
GlobeNewswire Inc.
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
07/24 07:10 pm
GlobeNewswire Inc.
Read moreSRPT Investors Have Opportunity to Join Sarepta Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
07/21 10:15 am
Benzinga
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
07/20 11:44 am
GlobeNewswire Inc.
Read moreINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sarepta Therapeutics
07/20 10:46 am
GlobeNewswire Inc.
Read moreSRPT BREAKING NEWS: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Announces Third Death -- Contact BFA Law by the August 25 Class Action Deadline
07/18 03:15 pm
GlobeNewswire Inc.
Read moreStocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What's Moving Markets Friday?
07/18 01:18 pm
Benzinga
Read moreSRPT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
07/17 05:30 pm
GlobeNewswire Inc.
Read moreHansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results
07/17 01:43 am
Benzinga
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers and Sarepta and Encourages Investors to Contact the Firm
07/16 07:53 pm
GlobeNewswire Inc.
Read moreSRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
07/14 10:16 am
Benzinga
Read moreBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm
07/12 03:37 pm
GlobeNewswire Inc.
Read more